About Neurable
Neurable is a company based in Boston (United States) founded in 2015 by Ramses Alcaide and Adam Eizenberg Molnar. Neurable has raised $56.56 million across 7 funding rounds from investors including Ultratech Capital Partners, TRAC and Pace Ventures. Neurable offers products and services including MW75 Neuro and Neurable Research Kit. Neurable operates in a competitive market with competitors including MindPortal, Ixana, Cognixion, NeuroSky and Nexstem, among others.
- Headquarter Boston, United States
- Founders Ramses Alcaide, Adam Eizenberg Molnar
-
Sectors
Technology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$56.56 M (USD)
in 7 rounds
-
Latest Funding Round
$35 M (USD), Series A
Dec 19, 2025
-
Investors
Ultratech Capital Partners
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neurable
Neurable offers a comprehensive portfolio of products and services, including MW75 Neuro and Neurable Research Kit.
Headphones integrating BCI for brain signal processing and daily use.
Kit for developing and testing BCI applications in research.
People of Neurable
Unlock access to complete
Unlock access to complete
Funding Insights of Neurable
Neurable has successfully raised a total of $56.56M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $35 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Neurable
Neurable has secured backing from 8 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Ultratech Capital Partners, TRAC and Pace Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Investments are made by TRAC in early-stage technology startups.
|
Locked | Locked | Locked | |
|
Early-stage venture capital investments are made by Pace Ventures.
|
Locked | Locked | Locked |
Investor details for Neurable
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neurable
Investment portfolio details for Neurable
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neurable
Detailed financials for Neurable
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neurable Comparisons
Peer comparison for Neurable
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neurable
Neurable operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MindPortal, Ixana, Cognixion, NeuroSky and Nexstem, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A wearable device for brain analysis and assessment is provided.
|
|
| Locked | Locked | Locked |
An AR-based headset for personal assistance is developed.
|
|
| Locked | Locked | Locked |
An AI and AR application for speech-impaired users is developed.
|
|
| Locked | Locked | Locked |
Neurotechnology solutions are developed by NeuroSky since 2004.
|
|
| Locked | Locked | Locked |
Non-invasive BCI solutions for EEG data are developed by Nexstem.
|
Detailed competitors of Neurable
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neurable
Complete news archive for Neurable
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neurable
Neurable was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Neurable is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Ramses Alcaide is the current CEO of Neurable. They have also founded this company.
Neurable is a funded company, having raised a total of $56.56M across 7 funding rounds to date.
Neurable was founded in 2015 in Boston, United States, and focuses on brain-computer interface technology within the neurotechnology sector. Brain signals are utilized by users to interact with devices, with integrations made into existing hardware for focus tracking and fatigue prevention. Operations emphasize accessibility for non-research applications, while future uses in wellness and clinical diagnostics are planned.
Neurable offers MW75 Neuro and Neurable Research Kit.
Neurable has 8 investors. Key investors include Ultratech Capital Partners, TRAC, Pace Ventures, Metaplanet, and National Science Foundation.